According to a new report, published by KBV research, The Global Flow Cytometry Market size is expected to reach $7.7 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.
The Diagnostic segment is showcasing a CAGR of 9.8% during (2022 - 2028). The surging growth of the segment is due to the increased usage of technology in diagnostic applications. Moreover, the rise in R&D efforts for infectious diseases like COVID-19 and cancer can also be ascribed to the increasing growth. Additionally, it is anticipated that rising R&D expenditures in the pharmaceutical and biotechnology sectors would drive the expansion of this segment.
The Commercial Organizations segment acquired maximum revenue share in the Global Flow Cytometry Market by End User in 2021 thereby, achieving a market value of $2.7 billion by 2028. The growth of this segment of the market is propelled by significant investments in R&D activities, developments in cell- and bead-based innovations, an expanding patient population, and rising demand for flow cytometry in the drug discovery process.
The Bead Based segment has shown the growth rate of 10.5% during (2022 - 2028). The rise in the growth of the segment is due to the technology's extensive use in research applications, reduced time requirements, and ability to analyze several samples at once. Moreover, the growth of the segment is also boosted due to its widespread use in the diagnosis of numerous illnesses, including cancer and HIV biomedical research, and its expanding application in tracking the effectiveness of drug therapy.
The Instruments segment is generating highest revenue share the Global Flow Cytometry Market by Component in 2021 thereby, achieving a market value of $2.7 billion by 2028. The growth of the segment is due to the development of novel instrument designs, the demand for highly efficient interchangeable components, applications in the treatment of newer diseases, as well as an increase in research and developments within flow cytometry technologies.
The North America market dominated the Global Flow Cytometry Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2.8 billion by 2028. The Europe market is exhibiting a CAGR of 7.9% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 8.9% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/flow-cytometry-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Danaher Corporation, Becton Dickinson and Company, BioMérieux S.A., Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Miltenyi Biotec B.V. & Co. KG, Sartorius AG, and Sysmex Corporation.
By Application
By End User
By Technology
By Component
By Geography
Companies Profiled
Unique Offerings 
